Startup profile · funding coverage
XRlabs funding, valuation and investors
Surgical software connecting patient-specific imaging and operating-room devices.
Keep track of XRlabs
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$8.4M · October 19, 2026
Latest known valuation
Not disclosed
Seed · October 19, 2026
Total disclosed equity funding
$8.4M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · London, United Kingdom
Overview
XRlabs is a London-headquartered surgical technology company founded by neurosurgeon Dr. Ali Haddad, with a Palo Alto office. XRlabs SIM supports patient-specific planning using imaging-derived digital twins. SurgicalOS is being developed to combine surgical video, navigation and imaging; the company explicitly describes this intraoperative system as under evaluation, not commercially available. On October 19, 2026, XRlabs announced $8.4M in seed funding led by Playground Global with participation from Eka Ventures. Its valuation, investor allocations and exact legal closing date were not disclosed.
Why XRlabs is interesting
XRlabs is pursuing a software layer across existing surgical equipment rather than a replacement-hardware sale. Its commercial opportunity depends on repeatable integrations, clinical evidence and hospital purchasing economics; SurgicalOS remains under development and is not commercially available.
Product & use cases
XRlabs SIM is a planning and visualization product. SurgicalOS is a separate in-development operating-room integration layer. Research evaluations should not be treated as commercial authorization or proven outcome improvement.
Key facts
- Company-announced $8.4M seed financing on October 19, 2026.
- SurgicalOS is under development and not commercially available.
- UK AI Research Resource compute allocation is separate non-cash support, not part of the round.
Funding history (newest first)
Investors in our directory
Funds linked from XRlabs's profile — open a fund page for stage focus and related deal articles.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover XRlabs's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.